Hanuman Medical Foundation

There is still no cure for type 1 diabetes, despite decades of research and promises. Most people with the disease say that a “cure” should mean being able to live a healthy life, free of dependence on external insulin—and without using powerful drugs that suppress the body's immune response. Only one current line of research holds real hope for both in the near term: the therapy known as encapsulated islets or the bioartificial pancreas. Hanuman Medical Foundation supports this vital research through its work with the Islet Sheet Project, a long-term collaboration by a team of leading diabetes researchers and medical inventors.

The Islet Sheet Project expects to begin clinical trials in 2013. This can be life-changing news for people with type 1 diabetes and their loved ones. We're committed to real progress, not promises. Please read on … and   join us.

We believe this technology has significant potential to be considered a cure for type 1 diabetes.

—The authors of Targeting a Cure for Type 1 Diabetes

NEWS

Major Matching Grant Awarded to HMF for Islet Sheet Research

April 15, 2013

Over the weekend, Hanuman Medical Foundation received a very generous matching grant of $50,000 to encourage community-based funding for the Islet Sheet Project. This means Hanuman will begin an... READ MORE

Islet Sheet Team Presents First Large-Animal Data

October 19, 2012

At the 48th annual meeting of the EASD in Berlin, the Islet Sheet Project team presented the first data from its current study of the Islet Sheet in diabetic pigs at UC Irvine. READ MORE

ASK AN EXPERT

Have a question about diabetes research, especially about islet transplantation? Looking for sound advice about managing type 1 diabetes? Interested in the work of our foundation? Ask here, and an expert from the Hanuman team will respond.

Q.

There already are several large foundations that focus on a cure for type 1 diabetes—for example, JDRF and DRI. Why create another nonprofit foundation that can only siphon off some of the scarce contributions for very expensive research?

A.

That’s a key question, Michael. Hanuman Medical Foundation was created to fund essential research to test a particular modality of therapy for type 1 diabetes: the use of an alginate sheet to encapsulate living islet cells, implanted in patients with... READ MORE

Scott King

This blog is most often authored by Scott R. King, president and founder of Islet Sheet Medical, a biotechnology company working with Hanuman Medical Foundation. Scott was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and ameliorating the disease. The Sheet shares updates on our work and welcomes comments. Click the icon below for Scott's Twitter feed.

Research Update and 2013 Experimental Plan

May 22nd, 2013

Islet Sheet Research Background Hanuman Medical Foundation has been funding the Islet Sheet Project with the requirement that we move into the clinic as fast as possible. We restarted the project in 2009 with a plan to perfect the Islet Sheet in laboratory and rodent studies, then move on to the definitive large-animal model of... READ MORE

Islet Sheet Project Update

May 16th, 2013

It’s been months since I took family leave from writing The Sheet. I have much to report on the Islet Sheet Project. For the balance of 2013 we will engage in some focused, small-scale studies to address problems identified in the pig studies. More on that very soon. Here are some other developments that I’ll... READ MORE

Animated views of how the Islet Sheet with its encapsulated islets works

 

 

Watch a clip from the documentary film The Human Trial of Scott King describing how he was diagnosed with type 1. Learn more about the film.